These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 6798925)

  • 1. Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?
    Rastogi N; Frehel C; Ryter A; Ohayon H; Lesourd M; David HL
    Antimicrob Agents Chemother; 1981 Nov; 20(5):666-77. PubMed ID: 6798925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the cell envelope of Mycobacterium avium.
    David HL; Rastogi N; Clavel-Sérès S; Clément F; Thorel MF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):49-66. PubMed ID: 3630478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis.
    Rastogi N; Goh KS; David HL
    Antimicrob Agents Chemother; 1990 May; 34(5):759-64. PubMed ID: 2360816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative ultrastructure of Mycobacterium leprae and M. avium grown in experimental hosts.
    Rastogi N; Frehel C; Ryter A; David HL
    Ann Microbiol (Paris); 1982; 133(1):109-28. PubMed ID: 6180669
    [No Abstract]   [Full Text] [Related]  

  • 5. [Macrophage respiratory burst-triggering activity of transparent and opaque colonial variants of Mycobacterium avium complex].
    Tomioka H; Saito H; Sato K; Yamamoto Y; Uchida M; Yamada Y
    Kekkaku; 1989 Jun; 64(6):401-6. PubMed ID: 2796111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological changes induced by beta-lactam antibiotics in Mycobacterium avium-intracellulare complex.
    Mizuguchi Y; Ogawa M; Udou T
    Antimicrob Agents Chemother; 1985 Apr; 27(4):541-7. PubMed ID: 4004193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative electron microscopic study of mycobacteria].
    Kulikovskiĭ AV
    Veterinariia; 1979; (2):29-33. PubMed ID: 433135
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential identification of Mycobacterium fortuitum and Mycobacterium chelonei.
    David HL; Traore I; Feuillet A
    J Clin Microbiol; 1981 Jan; 13(1):6-9. PubMed ID: 6780604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques.
    Rastogi N; Goh KS; Wright EL; Barrow WW
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2287-95. PubMed ID: 7840559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium avium rough-to-smooth colony conversion resulting from growth in Tween 80 without presence of type-specific glycopeptidolipid antigens.
    Wright EL; Pourshafie M; Barrow WW
    FEMS Microbiol Lett; 1992 Nov; 77(1-3):209-16. PubMed ID: 1459410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The surfaces of colonies of Mycobacterium species studied in the scanning electron microscope].
    Putina TG; Pavlova IB
    Zh Mikrobiol Epidemiol Immunobiol; 1989 May; (5):3-8. PubMed ID: 2675500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage interaction with mycobacteria including M. leprae.
    Ryter A; Frehel C; Rastogi N; David HL
    Acta Leprol; 1984; 2(2-4):211-26. PubMed ID: 6398582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural and chemical studies on wall-deficient forms, spheroplasts and membrane vesicles from Mycobacterium aurum.
    Rastogi N; David HL
    J Gen Microbiol; 1981 May; 124(1):71-9. PubMed ID: 7033468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibilities of transparent, opaque, and rough colonial variants of Mycobacterium avium complex to various fatty acids.
    Saito H; Tomioka H
    Antimicrob Agents Chemother; 1988 Mar; 32(3):400-2. PubMed ID: 3364959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
    Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
    Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic consequences of red-white colony type variation in Mycobacterium avium.
    Cangelosi GA; Palermo CO; Bermudez LE
    Microbiology (Reading); 2001 Mar; 147(Pt 3):527-533. PubMed ID: 11238960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in drug susceptibility distribution and clinical characteristics between
    Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y
    J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797
    [No Abstract]   [Full Text] [Related]  

  • 19. The rough colony morphotype of
    Nishimura T; Shimoda M; Tamizu E; Uno S; Uwamino Y; Kashimura S; Yano I; Hasegawa N
    J Med Microbiol; 2020 Jul; 69(7):1020-1033. PubMed ID: 32589124
    [No Abstract]   [Full Text] [Related]  

  • 20. The electron-transparent zone in phagocytized Mycobacterium avium and other mycobacteria: formation, persistence and role in bacterial survival.
    Frehel C; Ryter A; Rastogi N; David H
    Ann Inst Pasteur Microbiol; 1986; 137B(3):239-57. PubMed ID: 3689590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.